FIELD: medicine.
SUBSTANCE: said pathology is simulated by subcutaneous introduction of native human plasma 0.025 ml/g of body weight into Syrian hamsters every second day. An amyloidprotector is presented by galavit 0.28 mg/kg introduced simultaneously for 60 days.
EFFECT: method is easily reproducible, provides effective correction of a nephropathic form of generalised amyloidosis promoting amyloidoclasia.
1 ex, 3 tbl, 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC FORM IN EXPERIMENTAL ANIMALS | 2011 |
|
RU2473133C2 |
METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATHIC CONDITION IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2386415C1 |
METHOD FOR PREVENTION OF SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2008 |
|
RU2381797C1 |
METHOD FOR SIMULATION OF EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2010 |
|
RU2446482C1 |
METHOD OF PREVENTING SYSTEMIC AMYLOIDOSIS AND ITS NEPHROPATIC FORM IN EXPERIMENTAL ANIMALS | 2009 |
|
RU2410764C1 |
METHOD FOR SIMULATING GENERALISED AMYLOIDOSIS IN ANIMALS | 2013 |
|
RU2536556C2 |
METHOD OF MODELLING EXPERIMENTAL AMYLOIDOSIS IN RATS | 2009 |
|
RU2410761C1 |
METHOD FOR PROPHYLAXIS AND TREATMENT OF SYSTEMIC AMYLOIDOSIS AND NEPHROPATHIC FORM THEREOF IN EXPERIMENTAL ANIMALS | 2004 |
|
RU2270672C1 |
METHOD OF SIMULATING AMYLOIDOSIS IN ANIMALS | 2008 |
|
RU2373581C1 |
METHOD FOR MODELING EXPERIMENTAL AMYLOIDOSIS IN ANIMALS | 2006 |
|
RU2306617C1 |
Authors
Dates
2013-01-20—Published
2011-03-29—Filed